Portal hypertension is a major consequence of chronic liver disease and underlies many of the life-threatening complications of cirrhosis. Elevated portal pressure leads to the development of gastroesophageal varices, ascites, splenomegaly, and portosystemic shunting. Variceal bleeding remains one of the most serious complications, associated with significant morbidity and mortality despite advances in care. Improved understanding of portal hemodynamics has led to more effective preventive and therapeutic strategies. Non-selective beta-blockers, endoscopic variceal ligation, and early risk stratification are central to current management. Interventional radiology techniques and shunt procedures play an important role in refractory cases. This topic highlights advances in diagnosis, prevention, and management of portal hypertension and variceal bleeding, with an emphasis on reducing bleeding risk and improving patient outcomes.
Title : Early and late evaluation of esophageal mucosectomy in surgical treatment of advanced esophageal achalasia
Jose Luis Braga De Aquino, Pontifical Catholic University of Campinas, Brazil
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Invention City, United States
Title : Nanoemulsions as a strategy to enhance gastrointestinal bioavailability and bioactivity of lipid based nutraceuticals
Pubali Dhar, University of Calcutta, India
Title : Professional dining and health
Yaffa Machnes, Bar-Ilan University, Israel
Title : Sickle cell liver disease: A multidisciplinary hemato-hepatology approach
Bandar Aljudaibi, King Faisal Specialists Hospital and Research Centre, Saudi Arabia
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, Department of Public Health of Romagna, Italy